Published Date: 26 Apr 2023
More than 90% of people in the world own or use a mobile phone, and many of us couldn't live without them. We carry them everywhere we go, use them in bed and the bathroom, and for many people, they are the first thing they see in the morning.
Read Full NewsAs part of NeurologyLive®'s Year in Review, take a look at some of the top ongoing clinical trials in Parkinson disease that may impact care.
ALS expert Sabrina Paganoni, MD, PhD, provided follow-up commentary on promising phase 1 data from the LUMINA trial testing Amylyx’s novel agent AMX0114 in patients with early-stage ALS.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on preventative migraine therapies!
Benjamin Greenberg, MD, MHS, a nationally recognized neuroimmunologist, spoke about the clinical impact of the latest NMOSD recommendations and their implications for diagnosis and care.
4 Psychiatry Headlines You Missed in December 2025
6 Nephrology Headlines You Missed in December 2025
Residential Neighborhood Disadvantage May Lower Kidney Transplant Access
1.
Men over 75 years old may be significantly more likely to commit suicide if they have cancer.
2.
CAR T cells improve patients' quality of life: a study
3.
Patient Endured 9 Years of Chemotherapy for Cancer He Never Had
4.
Second opinions don't significantly delay breast cancer treatment
5.
Screening tests that are non-invasive show promise in detecting colorectal cancer.
1.
New Frontiers in Diagnosing and Managing Myelodysplastic Syndromes (MASLD)
2.
Obesity is a major risk factor for cancer
3.
CEUS in Endometrial Cancer: A Tool for Early Myometrial Infiltration Detection
4.
Navigating the Complexities of Esophageal Cancer Staging
5.
The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
2.
CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC
3.
Navigating the Complexities of Ph Negative ALL - Part II
4.
Efficient Management of First line ALK-rearranged NSCLC - Part V
5.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation